Computational Models Forecast C. diff Infections Before They Develop
Scientists at Seattle’s Institute for Systems Biology (ISB) have developed a personalized modeling framework that can predict whether patients are likely to develop Clostridioides difficile (C. diff) infections before symptoms appear.
By analyzing gut microbiome data, the models can forecast risk and point to personalized probiotic interventions to prevent disease. “C. diff is an opportunist. It can lie in wait in the gut, living benignly, ready to cause disease when conditions allow. If we remove the opportunity, we neutralize the threat,” said Sean Gibbons, PhD, senior author on the study and associate professor at ISB. “Instead of reacting to disease, this gives us a path to prevent it before it starts.”
This research underscores the strength of Washington State’s biotech community in combining data science and biology to pioneer preventative healthcare solutions.